We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Big Pharma M&As Indicate Encroaching Competition from Biotechs, Specialties
Big Pharma M&As Indicate Encroaching Competition from Biotechs, Specialties
June 21, 2013
Pharma giants Johnson & Johnson, AstraZeneca and Teva have all made moves this month on disease-specific pharmaceutical acquisitions as the industry looks to compete with booming biotechs and specialty pharma companies through cautious portfolio expansion.